Bryan Carmichael

Bryan Carmichael

Director, Digital Innovation & Data Science Thermo Fisher Scientific
Bryan Carmichael

Conference Day Two - Wednesday 15th April

12:00 PM Presentation/Case Study: Beyond Guardrails: Thermo Fisher’s GenAI Playbook for Regulated Clinical Development

GenAI in clinical development must be governed, repeatable, and auditable. Bryan shares Thermo Fisher’s scaling approach - an isolated enterprise LLM, ring-fenced patient-impacting workflows, and a ruthless ROI path - applied across ~3,000 global clinical trials each year.

• Segmenting patient-impacting vs business tasks; apply stricter controls where harm possible exists.

• Operating isolated enterprise LLM with auditable prompts, retrieval, outputs, and lineage tracking.

• Prototyping small, fail fast; scale only with ROI and regulatory acceptance evidence.

A compliance-first blueprint you can defend to MHRA/FDA - controls, evaluation, documentation - and a funding cadence that prioritises value over novelty.


Check out the incredible speaker line-up to see who will be joining Bryan.

Download The Latest Agenda